Recent data from the Hong Kong Stock Exchange indicates that on May 19, Huitianfu Fund reduced its holding in REMEGEN (09995) by 160,000 shares. The transaction was executed at a price of HK$84.8306 per share, resulting in a total consideration of approximately HK$13.5729 million. Following this divestment, the fund's latest shareholding stands at 10.3745 million shares, representing a 4.97% stake in the company.